MICL regulates immune cellular responses during the collagen antibody-induced arthritis model, where MICL-deficient mice present an exacerbated disease that was also reproduced by administering MICL-blocking antibodies in wild-type mice (Redelinghuys et al, 2016). This evidence concerns the gene CLEC12A and arthritic joint disease.